Cargando…

CD11c(+)CD88(+)CD317(+) myeloid cells are critical mediators of persistent CNS autoimmunity

Natalizumab, a humanized monoclonal antibody (mAb) against α4-integrin, reduces the number of dendritic cells (DC) in cerebral perivascular spaces in multiple sclerosis (MS). Selective deletion of α4-integrin in CD11c(+) cells should curtail their migration to the central nervous system (CNS) and am...

Descripción completa

Detalles Bibliográficos
Autores principales:	Manouchehri, Navid, Hussain, Rehana Z., Cravens, Petra D., Esaulova, Ekaterina, Artyomov, Maxim N., Edelson, Brian T., Wu, Gregory F., Cross, Anne H., Doelger, Richard, Loof, Nicolas, Eagar, Todd N., Forsthuber, Thomas G., Calvier, Laurent, Herz, Joachim, Stüve, Olaf
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	National Academy of Sciences 2021
Materias:	Biological Sciences
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8040603/ https://www.ncbi.nlm.nih.gov/pubmed/33785592 http://dx.doi.org/10.1073/pnas.2014492118

Ejemplares similares

B cell-based therapies in CNS autoimmunity: differentiating CD19 and CD20 as therapeutic targets
por: Forsthuber, Thomas G., et al.
Publicado: (2018)

TLR3 agonism re‐establishes CNS immune competence during α4‐integrin deficiency
por: Hussain, Rehana Z., et al.
Publicado: (2018)

Distinctive transcriptomic and epigenomic signatures of bone marrow-derived myeloid cells and microglia in CNS autoimmunity
por: Manouchehri, Navid, et al.
Publicado: (2023)

Defining standard enzymatic dissociation methods for individual brains and spinal cords in EAE
por: Hussain, Rehana Z., et al.
Publicado: (2018)

α4-integrin deficiency in B cells does not affect disease in a T-cell–mediated EAE disease model
por: Hussain, Rehana Z., et al.
Publicado: (2019)

Lymph node-derived donor encephalitogenic CD4(+ )T cells in C57BL/6 mice adoptive transfer experimental autoimmune encephalomyelitis highly express GM-CSF and T-bet
por: Cravens, Petra D, et al.
Publicado: (2011)

PEG Minocycline-Liposomes Ameliorate CNS Autoimmune Disease
por: Hu, Wei, et al.
Publicado: (2009)

Targeted Therapy for HM1.24 (CD317) on Multiple Myeloma Cells
por: Harada, Takeshi, et al.
Publicado: (2014)

CD317 Promotes the survival of cancer cells through apoptosis-inducing factor
por: Li, Xin, et al.
Publicado: (2016)

Single-cell RNA-seq analysis of human CSF microglia and myeloid cells in neuroinflammation
por: Esaulova, Ekaterina, et al.
Publicado: (2020)

In vivo-expression profile and regulation of the antiviral restriction factor CD317/tetherin in humans
por: Erikson, Elina, et al.
Publicado: (2011)

The cytosolic N-terminus of CD317/tetherin is a membrane microdomain exclusion motif
por: Billcliff, Peter G., et al.
Publicado: (2013)

CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
por: Kay, Alasdair G., et al.
Publicado: (2022)

Corrigendum: CD317-Positive Immune Stromal Cells in Human “Mesenchymal Stem Cell” Populations
por: Kay, Alasdair G., et al.
Publicado: (2022)

Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations
por: Kersten, M J, et al.
Publicado: (2014)

Lung Epithelial Signaling Mediates Early Vaccine-Induced CD4(+) T Cell Activation and Mycobacterium tuberculosis Control
por: Das, Shibali, et al.
Publicado: (2021)

Should ocrelizumab be used in non-active primary progressive multiple sclerosis? Time for a re-assessment
por: Manouchehri, Navid, et al.
Publicado: (2021)

Memory CD4(+) T Cells in Immunity and Autoimmune Diseases
por: Raphael, Itay, et al.
Publicado: (2020)

CD200 in CNS tumor-induced immunosuppression: the role for CD200 pathway blockade in targeted immunotherapy
por: Moertel, Christopher L, et al.
Publicado: (2014)

Chimeric antigen receptor T cell-based targeting of CD317 as a novel immunotherapeutic strategy against glioblastoma
por: Hänsch, Lena, et al.
Publicado: (2023)

IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation
por: Cravens, Petra D., et al.
Publicado: (2016)

β-TrCP is dispensable for Vpu's ability to overcome the CD317/Tetherin-imposed restriction to HIV-1 release
por: Tervo, Hanna-Mari, et al.
Publicado: (2011)

BST2/CD317 counteracts human coronavirus 229E productive infection by tethering virions at the cell surface
por: Wang, Shiu-Mei, et al.
Publicado: (2014)

P317: ANTI-LEUKEMIA ACTIVITY OF CD70-DIRECTED IMMUNOTHERAPY IN B CELL PRECURSOR ACUTE LYMPHOBLASTIC LEUKEMIA
por: Sun, Qian, et al.
Publicado: (2023)

Efficacy of Disease Modifying Therapies in Progressive MS and How Immune Senescence May Explain Their Failure
por: Manouchehri, Navid, et al.
Publicado: (2022)

Biological Significance of Anti–SARS-CoV-2 Antibodies: Lessons Learned From Progressive Multifocal Leukoencephalopathy
por: Manouchehri, Navid, et al.
Publicado: (2020)

To the editors: Impact of mass vaccination on SARS-CoV-2 infections among multiple sclerosis patients taking immunomodulatory disease-modifying therapies in England
por: Tugemann, Bastian, et al.
Publicado: (2022)

CD4 T cell Responses in the CNS during SIV infection
por: Elizaldi, Sonny R, et al.
Publicado: (2023)

HIV-1 antagonism of CD317/tetherin is species-specific and involves Vpu-mediated proteasomal degradation of the intrinsic immunity factor
por: Goffinet, Christine, et al.
Publicado: (2009)

CD317 maintains proteostasis and cell survival in response to proteasome inhibitors by targeting calnexin for RACK1-mediated autophagic degradation
por: Cheng, Jian, et al.
Publicado: (2023)

Exposure of a Distinct PDCA-1(+) (CD317) B Cell Population to Agonistic Anti-4-1BB (CD137) Inhibits T and B Cell Responses Both In Vitro and In Vivo
por: Vinay, Dass S., et al.
Publicado: (2012)

MS CD49d(+)CD154(+) Lymphocytes Reprogram Oligodendrocytes into Immune Reactive Cells Affecting CNS Regeneration
por: Piatek, Paweł, et al.
Publicado: (2019)

HIV-1 Vpu Blocks Recycling and Biosynthetic Transport of the Intrinsic Immunity Factor CD317/Tetherin To Overcome the Virion Release Restriction
por: Schmidt, Sarah, et al.
Publicado: (2011)

CD79B and MYD88 Mutations in Splenic Marginal Zone Lymphoma
por: Trøen, Gunhild, et al.
Publicado: (2013)

The neonatal CNS is not conducive for encephalitogenic Th1 T cells and B cells during experimental autoimmune encephalomyelitis
por: Cravens, Petra D, et al.
Publicado: (2013)

A CD317/tetherin–RICH2 complex plays a critical role in the organization of the subapical actin cytoskeleton in polarized epithelial cells
por: Rollason, Ruth, et al.
Publicado: (2009)

Targeting “bad” B cells in multiple sclerosis: Could laquinimod be part of the armamentarium?
por: Forsthuber, Thomas G., et al.
Publicado: (2016)

Improving the anti-acute myeloid leukemia activity of CD123-specific engager T cells by MyD88 and CD40 co-stimulation
por: Vaidya, Abishek, et al.
Publicado: (2022)

Rituximab Therapy Reduces Organ-Specific T Cell Responses and Ameliorates Experimental Autoimmune Encephalomyelitis
por: Monson, Nancy L., et al.
Publicado: (2011)

CRTAM controls residency of gut CD4(+)CD8(+) T cells in the steady state and maintenance of gut CD4(+) Th17 during parasitic infection
por: Cortez, Victor S., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_fj6dq7v8fnmf35j8dvofqrmq20